EichorEICHOR
Location: Colchester Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Colchester

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Hemithyroidectomy or Total-Thyroidectomy in 'Low-risk' Thyroid Cancers
NA · Colchester Hospital · University College, London · NCT05604963Is Online Patient EducatioN Feasible in People With Patellofemoral Pain Whilst They Wait for Physiotherapy
NA · East Suffolk and North Essex NHS Foundation Trust · East Suffolk and North Essex NHS Foundation Trust · NCT06744257Study of Patients with Electrical Status Epilepticus in Sleep
Phase N/A · East Suffolk and North Essex NHS Foundation Trust · East Suffolk and North Essex NHS Foundation Trust · NCT06792396Sinus Disease in Young Children With Cystic Fibrosis
Phase N/A · University of Vermont · University of California, Los Angeles · NCT06191640Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
Phase 3 · Colchester Hospital, ESNEFT · University College, London · NCT04685616A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
Phase 2 · Colchester Hospital University NHS · Janssen Research & Development, LLC · NCT06500884A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With
Phase 3 · Colchester General Hospital · Hoffmann-La Roche · NCT05894239A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD
Phase 3 · Vermont Lung Center at the University of Vermont · Hoffmann-La Roche · NCT05878769Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Phase 2 · University of Vermont · Johns Hopkins University · NCT07059091A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Le
Phase 3 · Colchester General Hospital · Hoffmann-La Roche · NCT06790693A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leuke
Phase 3 · Colchester Hospital University NHS · Janssen Research & Development, LLC · NCT06852222A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · University of Vermont Medical Center · Janssen Research & Development, LLC · NCT05923073A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Phase 3 · Colchester General Hospital ( Site 5307) · Merck Sharp & Dohme LLC · NCT06966700Randomised Evaluation of Sodium Dialysate Levels on Vascular Events
Phase 4 · Colchester (Diaverum) · University of Sydney · NCT02823821A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary
Phase 2 · Research Site · AstraZeneca · NCT07082738A Study Evaluating the Safety and Efficacy of MINIject S+ in Subjects With Open Angle Glaucoma
NA · Colchester General Hospital · iSTAR Medical · NCT07009236WithHolding Enteral Feeds Around Blood Transfusion (International)
NA · East and North Essex NHS Foundation Trust - Colchester Hospi · IWK Health Centre · NCT05213806Renal Adjuvant MultiPle Arm Randomised Trial
Phase 3 · Colchester General Hospital · University College, London · NCT03288532American Lung Association (ALA) Lung Health Cohort
Phase N/A · University of Vermont · Johns Hopkins University · NCT04543461Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Phase 3 · Colchester Hospital · UMC Utrecht · NCT02735707A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D
Phase 3 · Research Site · AstraZeneca · NCT06878261Magnetic Resonance Tumour Regression Grade (mrTRG) as a Novel Biomarker - Phase III Non CTIMP Trial
NA · Colchester General Hospital · Imperial College London · NCT02704520Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breas
Phase 2/Phase 3 · Colchester General Hospital · Cambridge University Hospitals NHS Foundation Trust · NCT03150576Rituximab and Ibrutinib (RI) Versus Dexamethasone, Rituximab and Cyclophosphamide (DRC) as Initial Therapy for Waldenstr
Phase 2/Phase 3 · Colchester Hospital · University College, London · NCT04061512A Long-term Extension Study of PCI-32765 (Ibrutinib)
Phase 3 · Colchester Hospital University NHS · Janssen Research & Development, LLC · NCT01804686A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Pat
Phase 3 · Colchester Hospital · Imperial College London · NCT05085028MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera
Phase 3 · Colchester Hospital · University of Birmingham · NCT04116502
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.